CLINICAL_TRIALS
research
· 2026-01-08
Clinical Trial Update: MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)
Summary
An ongoing University of Minnesota trial is investigating magnetic resonance spectroscopy biomarkers in Gaucher disease type 3 and is currently recruiting parti…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Minnesota | Conditions: Gaucher Disease, Type 3 | Status: RECRUITING